latent infection, and in EBV-positive cancers, the gene facilitates tumor growth. By showing that USP7 inhibition is effective against EBV-positive cancers in preclinical testing, the Lieberman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback